FI913433A0 - Foerfarande foer foerhindrande eller begraensande av skada vid aoterstroemning av blod genom ett organ eller en vaevnad. - Google Patents

Foerfarande foer foerhindrande eller begraensande av skada vid aoterstroemning av blod genom ett organ eller en vaevnad.

Info

Publication number
FI913433A0
FI913433A0 FI913433A FI913433A FI913433A0 FI 913433 A0 FI913433 A0 FI 913433A0 FI 913433 A FI913433 A FI 913433A FI 913433 A FI913433 A FI 913433A FI 913433 A0 FI913433 A0 FI 913433A0
Authority
FI
Finland
Prior art keywords
eller
vaevnad
begraensande
aoterstroemning
skada
Prior art date
Application number
FI913433A
Other languages
English (en)
Other versions
FI109694B (fi
Inventor
Belle Herman Van
Laerhoven Willy Joannes Ca Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI913433A0 publication Critical patent/FI913433A0/fi
Application granted granted Critical
Publication of FI109694B publication Critical patent/FI109694B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A61K38/166—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Protection Of Pipes Against Damage, Friction, And Corrosion (AREA)
  • Dicing (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Golf Clubs (AREA)
  • Professional, Industrial, Or Sporting Protective Garments (AREA)
  • Branch Pipes, Bends, And The Like (AREA)
  • Paper (AREA)
  • External Artificial Organs (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI913433A 1989-11-22 1991-07-16 Menetelmä terapeuttisesti käyttökelpoisen (1)-(-)-2-(aminokarbonyyli)-N-(4-amino-2,6-dikloorifenyyli)-4-[5,5-bis-(4-fluorifenyyli)pentyyli]-1-piperatsiiniasetamidin valmistamiseksi FI109694B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US44014289A 1989-11-22 1989-11-22
US44014289 1989-11-22
EP9001985 1990-11-19
PCT/EP1990/001985 WO1991007967A2 (en) 1989-11-22 1990-11-19 Method of preventing or limiting reperfusion damage
SG118494A SG118494G (en) 1989-11-22 1994-08-20 Method of preventing or limiting reperfusion damage
SG118494 1994-08-20

Publications (2)

Publication Number Publication Date
FI913433A0 true FI913433A0 (fi) 1991-07-16
FI109694B FI109694B (fi) 2002-09-30

Family

ID=26664237

Family Applications (1)

Application Number Title Priority Date Filing Date
FI913433A FI109694B (fi) 1989-11-22 1991-07-16 Menetelmä terapeuttisesti käyttökelpoisen (1)-(-)-2-(aminokarbonyyli)-N-(4-amino-2,6-dikloorifenyyli)-4-[5,5-bis-(4-fluorifenyyli)pentyyli]-1-piperatsiiniasetamidin valmistamiseksi

Country Status (22)

Country Link
EP (2) EP0455789B1 (fi)
JP (1) JP2574585B2 (fi)
KR (1) KR0165686B1 (fi)
AT (2) ATE102831T1 (fi)
AU (1) AU632888B2 (fi)
CA (1) CA2044143C (fi)
CY (1) CY1869A (fi)
DE (2) DE69007471T2 (fi)
DK (2) DK0455789T3 (fi)
ES (2) ES2053208T3 (fi)
FI (1) FI109694B (fi)
HK (1) HK115095A (fi)
HU (1) HU215847B (fi)
IE (1) IE65121B1 (fi)
IL (1) IL96390A (fi)
NO (2) NO304519B1 (fi)
NZ (1) NZ236168A (fi)
PT (2) PT95959B (fi)
RU (1) RU2093156C1 (fi)
SG (1) SG118494G (fi)
WO (1) WO1991007967A2 (fi)
ZA (1) ZA909345B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
SE9904674D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
KR100915263B1 (ko) 2001-05-18 2009-09-03 아스트라제네카 아베 4(페닐-피페라지닐-메틸)벤즈아미드 유도체 및 통증, 불안증 또는 위장관 장애 치료를 위한 이들의 용도
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US20090018351A1 (en) * 2003-11-12 2009-01-15 Dr. Reddy's Laboratories, Inc. Preparation of escitalopram
MX2007001240A (es) 2004-08-02 2007-03-23 Astrazeneca Ab Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
FR2946340B1 (fr) 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
KR101900124B1 (ko) 2014-06-25 2018-09-18 전남대학교산학협력단 전복 박리용 조성물
KR101644299B1 (ko) 2014-07-22 2016-08-02 주식회사 엔바이로젠 오미자 및 삼채 추출물을 유효성분으로 포함하는 전복 박리용 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
NZ223847A (en) * 1987-04-01 1989-12-21 Janssen Pharmaceutica Nv Substituted piperazine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
NO982078L (no) 1991-08-26
HU9102436D0 (en) 1991-12-30
IE904209A1 (en) 1991-05-22
ATE213943T1 (de) 2002-03-15
DK0455789T3 (da) 1994-04-05
IE65121B1 (en) 1995-10-04
KR0165686B1 (ko) 1999-01-15
NO311701B1 (no) 2002-01-14
WO1991007967A2 (en) 1991-06-13
EP0455789A1 (en) 1991-11-13
PT102145B (pt) 2002-06-28
EP0577171A3 (en) 1994-06-29
PT102145A (pt) 1999-10-29
NO912511L (no) 1991-08-26
PT95959B (pt) 1998-08-31
EP0577171B1 (en) 2002-03-06
CA2044143A1 (en) 1991-05-23
CY1869A (en) 1996-04-05
IL96390A0 (en) 1991-08-16
DE69033926T2 (de) 2002-10-24
DE69033926D1 (de) 2002-04-11
AU6876391A (en) 1991-06-26
EP0577171A2 (en) 1994-01-05
DE69007471D1 (de) 1994-04-21
NZ236168A (en) 1993-05-26
ES2173883T3 (es) 2002-11-01
SG118494G (en) 1994-11-25
ZA909345B (en) 1992-08-26
CA2044143C (en) 2002-11-19
NO982078D0 (no) 1998-05-07
WO1991007967A3 (en) 1991-07-11
EP0455789B1 (en) 1994-03-16
DE69007471T2 (de) 1994-06-23
HUT58709A (en) 1992-03-30
PT95959A (pt) 1991-09-13
KR920700644A (ko) 1992-08-10
JP2574585B2 (ja) 1997-01-22
ES2053208T3 (es) 1994-07-16
NO912511D0 (no) 1991-06-26
ATE102831T1 (de) 1994-04-15
AU632888B2 (en) 1993-01-14
HK115095A (en) 1995-07-21
DK0577171T3 (da) 2002-06-03
HU215847B (hu) 1999-04-28
NO304519B1 (no) 1999-01-04
RU2093156C1 (ru) 1997-10-20
IL96390A (en) 1995-06-29
FI109694B (fi) 2002-09-30

Similar Documents

Publication Publication Date Title
FI913433A0 (fi) Foerfarande foer foerhindrande eller begraensande av skada vid aoterstroemning av blod genom ett organ eller en vaevnad.
DK48187A (da) 5,6-dihydro-2-(substitueret phenyl)-1,2,4-triazin-3,5(2h, 4h)-dioner
DK74691D0 (da) 4(4-(substitueret phenyl)-1-piperazinyl)phenoler og fremgangsmaade til fremstilling deraf
DE69206787D1 (de) 4-[(2-Benzothiazolyl)Methylamino]-alpha-(3,4-Difluorphenoxy)methyl-1-piperidenethanol
FI872930A0 (fi) Analogiamenetelmä ripulinvastaisten 4-(bentsoyyliamino)piperidiinibutaaniamidijohdannaisten valmistamiseksi